New research studies surrounding Retatrutide , specifically the high-dose formulation ZPHC ZPHC, suggest a impressive effect on body mass loss and linked metabolic conditions . Researchers anticipate that this innovative compound, targeting both GLP-1 and GIP pathways , has the potential to offe